TP53 and neoplasm: Contrastingly, p53-mutant or p53-loss tumor cells are more prone to undergo other cell death modes such as apoptosis or even escape the RT-induced cell cycle arrest for continuous dividing and growth, thus increasing the risk of treatment failure 112.